INCY CIK: 879169

Incyte Corp.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
3.12
FY22:
4.09
FY23:
4.65
FY24:
3.24
FY25:
5.02
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.81
FY22:
1.75
FY23:
2.14
FY24:
2.21
FY25:
1.93
Total assets
Change from FY21 to FY25
billions USD
FY21:
4.93
FY22:
5.84
FY23:
6.78
FY24:
5.44
FY25:
6.96

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.85
FY22:
1.16
FY23:
1.24
FY24:
1.64
FY25:
1.52
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.31
FY22:
0.31
FY23:
0.35
FY24:
0.35
FY25:
0.28
(positive)
Change from FY21 to FY25
billions USD
FY21:
3.77
FY22:
4.37
FY23:
5.19
FY24:
3.45
FY25:
5.17
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
4.93
FY22:
5.84
FY23:
6.78
FY24:
5.44
FY25:
6.96

All amounts in billions USD Data source:SEC EDGAR